Dr. Fauci launched his career by allowing Burroughs Wellcome (now GlaxoSmith-Kline) to charge $10,000 annually28 for azidothymidine (AZT), an antiretroviral medication developed exclusively by NIH and tested and approved by Dr. Fauci himself. Dr. Fauci knew that the product cost Burroughs Wellcome a mere $5/dose to manufacture.29 Higher profit for industry “partners” often means more extravagant royalty payments for his NIAID and NIH cronies.
